Drug details

Emend Injection (fosaprepitant dimeglumine injection)

type of Antiemetic Agents, NK1 Receptor Antagonists

Emend (fosaprepitant dimeglumine injection) is a substance P/neurokinin-1 (NK1) receptor antagonist that works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting and is used together with other medications to prevent nausea and vomiting that may be caused by cancer chemotherapy. Emend is given ahead of time and will not treat nausea or vomiting that is already present.

This drug may have the following side effects:

• tiredness,
• nausea,
• headache,
• dizziness,
• vomiting,
• diarrhea,
• weakness,
• constipation,
• loss of appetite,
• increased thirst,
• fever,
• chills,
• stomach pain,
• sleep problems (insomnia), or
• flu symptoms,
• ringing in your ears,
• heartburn,
• hiccups,
• body aches,
• hot and dry skin,
• pain or a hard lump where the medicine was injected

The following drugs are related to Emend Injection, either as a replacement or used together:

• Aloxi (palonosetron hydrochloride)
• Aloxi Capsules (palonosetron hcl capsules)
• Anzemet Injection (dolasetron mesylate injection)
• Anzemet Tablets (dolasetron)
• Aponvie (aprepitant injectable emulsion)
• Focinvez (fosaprepitant injection)
• Kytril (granisetron)
• Kytril Injection (granisetron hydrochloride)
• Sancuso (granisetron transdermal system)
• Istodax (romidepsin for injection)
• Zofran Injection (ondansetron hydrochloride injection)
• Zofran (ondansetron hydrochloride tablets and solution)
• Varubi (rolapitant tablets)